These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3073383)

  • 1. Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.
    Legg B; Rowland M
    Pharm Res; 1988 Feb; 5(2):80-5. PubMed ID: 3073383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.
    Legg B; Rowland M
    Ther Drug Monit; 1988; 10(1):16-9. PubMed ID: 3376178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model to account for the blood-to-plasma distribution of cyclosporin A in human blood.
    Shibata N; Minouchi T; Ono T; Shimakawa H
    J Pharmacobiodyn; 1990 Jan; 13(1):20-9. PubMed ID: 2341967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B; Gupta SK; Rowland M; Johnson RW; Solomon LR
    Eur J Clin Pharmacol; 1988; 34(5):451-60. PubMed ID: 3203704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Apr; 27(4):475-81. PubMed ID: 2655690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized method for measuring cyclosporin A with 125I-labeled cyclosporin.
    Felder RA; Mifflin TE; Bastani B
    Clin Chem; 1986 Jul; 32(7):1378-82. PubMed ID: 3521944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin: measurement of fraction unbound in plasma.
    Legg B; Rowland M
    J Pharm Pharmacol; 1987 Aug; 39(8):599-603. PubMed ID: 2888849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between apparent total body clearance of cyclosporin A and its erythrocyte-to-plasma distribution ratio in renal transplant patients.
    Shibata N; Minouchi T; Yamaji A; Park KI; Inoue H; Tomoyoshi T; Sako H; Abe H; Kodama M; Nakane Y
    Biol Pharm Bull; 1995 Jan; 18(1):115-21. PubMed ID: 7735224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte uptake and protein binding of cyclosporin A (CyA) in human blood: factors affecting CyA concentration in erythrocytes.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Jul; 16(7):702-7. PubMed ID: 8401406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of cyclosporin A in whole blood and plasma by high performance liquid chromatography.
    Shibata N; Minouchi T; Hayashi Y; Ono T; Shimakawa H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):261-71. PubMed ID: 3310157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
    Rosano TG
    Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients.
    Takada K; Yoshikawa H; Muranishi S; Nagano S; Fukunishi T
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):438-42. PubMed ID: 3308718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for predicting the cyclosporin A erythrocyte-to-plasma distribution ratio in blood, and its clinical assessment.
    Shibata N; Yamaji A; Park K; Tomoyoshi T; Sako H; Abe H; Kodama M; Nakane Y; Hodohara K; Hosoda S
    Biol Pharm Bull; 1994 May; 17(5):709-14. PubMed ID: 7920439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clarithromycin on the bioavailability of cyclosporin in rats.
    Ohba M; Ohnishi N; Komada F; Iwakawa S; Okumura K
    Biol Pharm Bull; 1996 May; 19(5):733-7. PubMed ID: 8741585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of temperature and endogenous factors in blood on concentrations of cyclosporin in plasma measured by high-performance liquid chromatography.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1877-80. PubMed ID: 2805168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.
    Lemaire M; Tillement JP
    J Pharm Pharmacol; 1982 Nov; 34(11):715-8. PubMed ID: 6129301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between cyclosporin and diltiazem.
    Brockmöller J; Neumayer HH; Wagner K; Weber W; Heinemeyer G; Kewitz H; Roots I
    Eur J Clin Pharmacol; 1990; 38(3):237-42. PubMed ID: 2340843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants.
    Lindholm A; Henricsson S
    Ther Drug Monit; 1989 Nov; 11(6):623-30. PubMed ID: 2595741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bile on cyclosporin absorption in liver transplant patients.
    Mehta MU; Venkataramanan R; Burckart GJ; Ptachcinski RJ; Delamos B; Stachak S; Van Thiel DH; Iwatsuki S; Starzl TE
    Br J Clin Pharmacol; 1988 May; 25(5):579-84. PubMed ID: 3044424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.